Procedures | Schedule | ||||||||||||||
Day 1 | Day 2 | Day 3 | Day 4 | Day 5 | Day 6 | Day 7 | Day 8 | Day 9 | Day 10 | Day 11 | Day 12 | Day 13 | Day 14 | ||
Screening | Baseline | ||||||||||||||
Informed consent for screening | X | ||||||||||||||
Participant details and demographics | X | ||||||||||||||
GeneXpert Influenza point of care test | X | ||||||||||||||
Past medical and surgical history | X | ||||||||||||||
Concomitant medications | X | X | X | ||||||||||||
Eligibility assessment | X | ||||||||||||||
Physical examination | X | ||||||||||||||
Informed consent for appropriate study | X | ||||||||||||||
Randomisation | X | ||||||||||||||
Baseline symptom score (MJS) | X | ||||||||||||||
Participant training in device warnings | X | ||||||||||||||
Device checks | X | X | |||||||||||||
Day 1 treatment administered | X | ||||||||||||||
Treatment administered at home | X | X | X | X | |||||||||||
Participant symptom diary, including MJS | X | X | X | X | X | X | X | X | X | X | X | X | X | ||
MRINZ clinic visit | X | X | |||||||||||||
Devices returned | X | ||||||||||||||
Tolerability questionnaire | X | ||||||||||||||
Follow-up phone call | X | ||||||||||||||
Adverse event assessments | X | X | X | ||||||||||||
Arrange reimbursement | X |
MJS, Modified Jackson Score; MRINZ, Medical Research Institute of New Zealand.